Palvella Therapeutics PVLA Non Cash Lease Operating Expense
Non Cash Lease Operating Expense at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept pvla:NonCashLeaseOperatingExpense.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's non cash lease operating expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's non cash lease operating expense?
- Palvella Therapeutics (PVLA) reported non cash lease operating expense of $44K in Q1 2026.
- What does non cash lease operating expense mean?
- Includes non-cash expenses related to operating leases, such as the amortization of right-of-use assets and the unwinding of lease liabilities. This adjustment is necessary to reconcile net income to cash flow from operations by removing accounting charges that do not represent actual cash payments. It allows for a clearer view of the company's recurring cash operating obligations.